UK approves Pfizer coronavirus vaccine for use 'from next week'

A COVID-19 vaccine is a vaccine intended to provide acquired immunity against COVID-19.
'Historic moment' allows mass immunisation, with 800,000 doses expected to be available next week
The vaccine has been authorised for emergency use by the Medicines and Healthcare products Regulatory Authority (MHRA), before decisions by the US and Europe. The MHRA was given power to approve the vaccine by the government under special regulations before 1 January, when it will become fully responsible for medicines authorisation in the UK after Brexit.
Pfizer and BioNTech say they've won permission Wednesday for emergency use of their COVID-19 vaccine in Britain, the world's first coronavirus shot that's backed by rigorous science. and a major step toward eventually ending the pandemic. The move makes Britain one of the first countries to begin vaccinating its population as it tries to curb Europe's deadliest COVID-19 outbreak. Pfizer gained 4% to Rs5317
The total number of vaccines brought by the EU is 300m doses of BioNTech-Pfizer.That shoud suffice their needs. As the EU Citizens feels safe from COVID now.It is a growth point of time for the pharma companies. Intead those who brought it are in the profit stage. Thus, market research at every step helps analysing the current trends in market and gain maximum profits.